Search
Amgen Inc
AMGNAdd to Watchlist
337.600USD
-4.060-1.19%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
182.20BMarket Cap
23.31P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Amgen Inc is 6.89, ranking 121 out of 157 in the Pharmaceuticals industry. The average price target is 323.50, with a high of 400.00 and a low of 180.00.
Analyst Rating
Based on
38
analysts
Hold
Current Rating
359.556
Target Price
+6.50%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
175
Total
6
Median
8
Average
Company name
Ratings
Analysts
Amgen Inc
AMGN
38
Biogen Inc
BIIB
38
Eli Lilly and Co
LLY
35
Vertex Pharmaceuticals Inc
VRTX
34
AbbVie Inc
ABBV
34
Bristol-Myers Squibb Co
BMY
32
1
2
3
...
35
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Amgen Inc's expected revenue for the next quarter?
Amgen Inc's expected revenue is 9.42B.
What is Amgen Inc's price target?
Analysts forecast that Amgen Inc's price target is USD 323.50, with the highest forecast at USD 400.00 and the lowest forecast at USD 180.00.
How have Amgen IncAMGN's recent earnings per share performed?
The market expectation was USD 3.37, while Amgen IncAMGN's earnings per share (EPS) for the previous quarter was USD 2.48. EPS for the next quarter is expected at USD 5.60.
What is the analyst rating for Amgen Inc?
Based on the ratings of Amgen Inc's stock from 38 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.
